Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
Pimecrolimus, which is an ascomycin derivative, is an anti-inflammatory non-steroidal agent.
In this study, the long-term safety and efficacy of pimecrolimus cream will be evaluated in
Japanese adult patients with atopic dermatitis. This study is a 6-month extension study
following core study.
THIS STUDY IS NOT ENROLLING PATIENTS IN THE UNITED STATES